About this trial

The goal of this project is to test the effects of the VibraCool mechanical stimulation neuromodulatory therapeutic device on post-operative pain and opioid use following anterior crucitate ligament reconstruction (ACLR), and thus residual opioids in circulation.

Eligibility criteria

Qualifiers

Underwent ACL reconstruction

Disqualifiers

Pediatric iliotibial band ACL reconstruction (known to cause significantly more pain)

Non-english speakers (limitations of our study group)

Trial design

Treatments tested in this trial

  • VibraCool mechanical stimulation and neuromodulatory therapeutic device
  • Cryocompression (Game Ready, Bregs) device
  • Standard ice packs

Treatment groups

130 Participants
are divided into 3 treatment groups

Locations

1
Columbia University Medical Center10032, New YorkNew York, United States

Sponsors and collaborators

Columbia University

Lead sponsor